Your browser doesn't support javascript.
loading
Prognostic impact of ASXL1 mutations in chronic phase chronic myeloid leukemia.
Bidikian, Aram; Kantarjian, Hagop; Jabbour, Elias; Short, Nicholas J; Patel, Keyur; Ravandi, Farhad; Sasaki, Koji; Issa, Ghayas C.
Afiliação
  • Bidikian A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Patel K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. gcissa@mdanderson.org.
Blood Cancer J ; 12(10): 144, 2022 10 28.
Article em En | MEDLINE | ID: mdl-36307398
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide Idioma: En Ano de publicação: 2022 Tipo de documento: Article